Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2014

Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract]

Financial assets measured at fair value on a recurring basis

The Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis was as follows (in thousands):



	March 31, 2014								December 31, 2013
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets:
Money market funds	$	23,083	$	—	$	—	$	23,083	$	23,695	$	—	$	—	$	23,695
Rabbi Trust:
Mutual funds	29,926		—		—		29,926		28,945		—		—		28,945
Money market funds	4,965		—		—		4,965		5,737		—		—		5,737
Total assets	$	57,974	$	—	$	—	$	57,974	$	58,377	$	—	$	—	$	58,377
Liabilities:
Payables to plan participants	$	34,891	$	—	$	—	$	34,891	$	34,682	$	—	$	—	$	34,682
Acquisition contingent liability	—		—		8,202		8,202		—		—		8,110		8,110
Total liabilities	$	34,891	$	—	$	8,202	$	43,093	$	34,682	$	—	$	8,110	$	42,792

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table provides a summary of changes in fair value of the Company's Level 3 financial assets (in thousands):



	Estimated Fair Value
Balance at December 31, 2013	$	8,110
Included in earnings	92		⁽¹⁾
Balance at March 31, 2014	$	8,202


(1)	Accretion of the present value of the contingent liability is recorded in interest expense and other in the Company's consolidated statements of comprehensive income. A 1 percent change in the discount rate would have an impact on the fair value of the contingent liability of approximately $0.2 million.

Carrying amount and estimated fair value of financial instruments

The carrying amount and estimated fair value of the Company’s other financial instruments were as follows (in thousands):



	March 31, 2014				December 31, 2013
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets:
Note receivable from CareCentrix	$	25,000	$	26,836	$	25,000	$	26,403
Seller financing note receivable from CareCentrix	3,471		3,471		3,471		3,471
Liabilities:
Long-term obligations	$	1,172,419	$	1,181,202	$	1,177,000	$	1,183,863

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References+ Details

- Definition

Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.

+ References+ Details

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References+ Details